Received: 16 July 2020
Accepted: 18 August 2020
First Online: 25 August 2020
Ethics approval and consent to participate
: All patients gave their informed consent. Local ethics committee approved the study protocol (reference code 2020-113-1), registered by the Spanish Agency of Medicines and Health Products with the reference code GETCLO-2020-01 and by the European Medicines Agency with the reference code EUPAS34365EBMT.
: The participants provided informed consent for the publication of the study.
: The author(s) declare that they have no conflict of interests.